Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Intraosseous Infusion Devices Market, by Product Type, by Technology, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 ...
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb 3, 2016) - Pyng Medical Corp. (TSX VENTURE:PYT), an award-winning developer of trauma and resuscitation products for emergency, combat and critical care ...
DUBLIN, April 14, 2022 /PRNewswire/ -- The "Intraosseous Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, ...
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
The PortIO Intraosseous Infusion System consists of an implantable intraosseous vascular access device and insertion kit. Instead of a catheter located in a vein, it has a short extension from the ...
VANCOUVER, British Columbia, Jan. 10, 2012 /PRNewswire/ -- Pyng Medical Corp. (the "Company") (PYT: TSX-V) announced today that the FAST1® has been chosen by the Spanish Army through Pyng's exclusive ...
Please provide your email address to receive an email when new articles are posted on . According to published results, an intraosseous infusion of antibiotics combined with morphine offered ...
NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that its ...
Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Intraosseous vancomycin infusion during total hip arthroplasty was feasible for timely delivery of ...
According to forecasts, the Intraosseous Infusion Devices Market would be valued US$ 4.4 billion in 2023 and US$ 8.6 billion by 2033. Sales of intraosseous infusion devices are anticipated to grow at ...
According to forecasts, the Intraosseous Infusion Devices Market would be valued US$ 4.4 billion in 2023 and US$ 8.6 billion by 2033. Sales of intraosseous infusion devices are anticipated to grow at ...
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results